Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0324 per EA under NDC 16571086801. Its NADAC has been published 187 times since Nov 30, 2022.
Strength
300 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571086801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207099On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 187 times since Nov 30, 2022, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0324 per EA |
|---|---|
| All-time high | $0.0457 (Sep 13, 2023) |
| All-time low | $0.0313 (Nov 20, 2024) |
| 52-week high | $0.0361 |
| 52-week low | $0.0324 |
| Median price | $0.0377 |
| Average price | $0.0381 |
| Largest weekly change | -17.0% (Nov 20, 2024) |
| Weeks tracked | 187 |
| Tracking since | Nov 30, 2022 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0324 per EA (NDC 16571086801), effective Jun 24, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 23.1%. It has been tracked across 187 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Nov 30, 2022, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0313 (Nov 20, 2024) to a high of $0.0457 (Sep 13, 2023), with a median of $0.0377 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
9 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 300 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 16571086801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification